Nsight Barbara Nelsen on the business of science.

You can’t have a rich biotech ecosystem without critical mass

Published August 13, 2014. Filed under Biomedical, Business growth, Biotech funding, Life science, Pharmaceutical

Catching up on Minnesota news in the Star Tribune a few weeks ago, the following headline caught my eye: “Minnesota loses when tech firms head… Read more

Corporate venture capital: Science First.

Published May 13, 2014. Filed under Biomedical, Business growth, Biotech funding, Startup financing, Venture capital, Strategy, Life science, Medtech

I recently spoke with several corporate venture capital investors (CVCs) when I moderated a panel at the 2014 RESI Conference. The discussion gave definition about… Read more

Getting to know you: Do’s and Dont’s for Networking in the Life Sciences

Published March 31, 2014. Filed under Biomedical, Business growth, Career, Life science

Much has been written about the importance of networking, but it’s so important that we think it bears revisiting, customized for entrepreneurs in the life… Read more

Regenerative Medicine. De-risking for funding,devaluing for patients?

Published February 2, 2014. Filed under Research tools, Business growth, Biotech funding, Strategy, Life science

Regenerative medicine – “the process of creating living, functional tissues to repair or replace tissue or organ function lost due to age, disease, damage, or… Read more

Where in the World? Hotspots for Growing your Life Science Company

Published December 6, 2013. Filed under Research tools, Business growth, Biotech funding, Startup financing, Venture capital, Diagnostics, Government funding, Life science, Medtech, Pharmaceutical

On November 20th I hosted a panel of experts representing medical devices, diagnostics, research tools, and biopharma at Minnesota’s LifeScience Alley’s 2013 annual conference. The… Read more

Categories